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INTRODUCTION	
  
	
  
Influenza	
  A	
  viruses	
  are	
  classified	
  using	
  the	
  an5genic	
  and	
  phylogene5c	
  characteris5cs	
  of	
  the	
  
envelope	
  glycoproteins	
  haemagglu5nin	
  (HA)	
  and	
  neuraminidase	
  (NA).	
  Currently	
  17	
  different	
  
haemagglu5nin	
   subtypes	
   are	
   recognized	
   and	
   are	
   divided	
   into	
   two	
   lineages:	
   Group	
   1	
   and	
  
Group	
   2	
   (Figure	
   1).	
   In	
   humans	
   influenza	
   A	
   viruses	
   that	
   harbour	
   on	
   their	
   envelope	
  
haemagglu5nin	
  of	
  H1	
  and	
  H3	
  subtypes	
  usually	
  circulate,	
  cause	
  seasonal	
  epidemics	
  and	
  are	
  
included	
   in	
   the	
  seasonal	
  vaccine.	
  However	
  viruses	
  with	
  other	
  HA	
  subtypes	
   (eg	
  H5,	
  H7,	
  H9)	
  
have	
  been	
   shown	
   to	
   infect	
  humans	
  and	
   if	
   these	
  viruses	
  acquire	
  efficient	
  human-­‐to-­‐human	
  
transmission	
  they	
  can	
  poten5ally	
  cause	
  pandemics.	
  
The	
  study	
  of	
  heterosubtypic	
  an5body	
  responses	
  directed	
  
against	
   influenza	
   A	
   haemagglu5nins	
   in	
   human	
  
popula5ons	
   is	
   an	
   important	
   facet	
   of	
   pandemic	
  
preparedness.	
   For	
   this	
   purpose	
   it	
   is	
   important	
   to	
   study	
  
whether	
   seasonal	
   vaccina5on	
   can	
   elicit	
   and/or	
   boost	
   a	
  
cross-­‐neutralizing	
  an5body	
  response.	
  	
  
Classical	
   serological	
   assays,	
   such	
   as	
   haemagglu5na5on	
  
inhibi5on	
   and	
   microneutraliza5on,	
   have	
   demonstrated	
  
low	
   sensi5vity	
   for	
   the	
   detec5on	
   of	
   cross-­‐neutralizing	
  
an5bodies,	
  especially	
   those	
  directed	
  against	
  epitopes	
   in	
  
the	
   haemagglu5nin	
   HA2	
   stalk	
   region.	
   Here	
   we	
   use	
  
pseudotype	
   par5cle	
   neutraliza5on	
   assays	
   performed	
  
using	
   representa5ves	
   of	
   Group	
   2	
   influenza	
   viruses	
   to	
  
detect	
   the	
   presence	
   of	
   heterosubtypic	
   neutralizing	
  
an5body	
   against	
   Group	
   2	
   viruses	
   before	
   and	
   aTer	
  
seasonal	
  vaccina5on.	
  
	
  
MATERIALS	
  AND	
  METHODS	
  
	
  
Sera	
  
Sera	
  from	
  18-­‐60	
  year	
  old	
  people	
  (13)	
  and	
  from	
  elderly	
  (9)	
  collected	
  before	
  and	
  aTer	
  seasonal	
  
vaccina5on	
   with	
   A/Wisconsin/67/2005	
   (H3N2),	
   A/Solomon	
   Island/3/2006	
   (H1N1)	
   and	
   B/
Malayasia/2506/2004	
  were	
  used	
  for	
  this	
  study.	
  	
  
	
  
Pseudotype	
  par;cles	
  produc;on	
  and	
  ;tra;on	
  
Len5viral	
  pseudotypes	
  were	
  produced	
  as	
  described	
  previously	
  [4,	
  5,	
  6].	
  Briefly,	
  HIV	
  gag-­‐pol	
  
plasmid	
   p8.91,	
   firefly	
   luciferase	
   expressing	
   plasmid	
   pCSFLW,	
   HA	
   expressing	
   plasmid	
   and	
  
pCAGGS-­‐TMPRSS2	
   [3]	
  were	
  co-­‐transfected	
   into	
  human	
  embryonic	
  kidney	
  HEK293T/17	
  cells	
  
using	
   Fugene-­‐6	
   transfec5on	
   reagent	
   (Roche,	
   UK).	
   ATer	
   24	
   hours	
   incuba5on,	
   recombinant	
  
neuraminidase	
  from	
  Clostridium	
  perfringens	
  (Sigma)	
  was	
  added	
  to	
  facilitate	
  pseudotype	
  exit	
  
from	
   the	
   producer	
   cells.	
   48	
   hours	
   post-­‐transfec5on	
   supernatant	
   was	
   harvested,	
   filtered	
  
through	
  0.45μm	
  filters	
  and	
  stored	
  at	
   -­‐80°C.	
  Calcula5on	
  of	
   the	
  pseudotype	
  5tres	
   in	
   rela5ve	
  
luminescence	
   units	
   (RLU)	
   per	
  ml	
  was	
   carried	
   out	
   as	
   described	
   by	
   us	
   elsewhere	
   [6,	
   poster	
  
P2-­‐493].	
  
	
  
Pseudotype	
  par;cles	
  neutraliza;on	
  assay	
  
Neutraliza5on	
   5tres	
   of	
   each	
   sera	
   were	
   evaluated	
   against	
   A/Udorn/307/1972	
   H3,	
   A/duck/
Czechoslovakia/1956	
  H4,	
  A/chicken/Italy/1082/1999	
  H7,	
   	
  A/chicken/Germany/N49	
  H10,	
  A/
mallard/Astrakhan/263/1982	
   H14,	
   A/shearwater/West	
   Australia/2576/1979	
   H15	
  
pseudotypes.	
  
Serial	
  dilu5ons	
  (1:40-­‐1:5120)	
  of	
  pre	
  and	
  post	
  vaccina5on	
  sera	
  and	
  of	
  posi5ve	
  control	
  sera	
  in	
  
white	
   96-­‐well	
   flat-­‐boiomed	
   5ssue	
   culture	
   plates	
   (Nunc)	
   in	
   a	
   final	
   volume	
   of	
   50μl	
   were	
  
performed	
   and	
  1x106	
  RLU/well	
   of	
   pseudotypes	
  were	
   added	
   to	
   the	
  plate.	
   Following	
   1	
   hour	
  
incuba5on	
   at	
   37°C,	
   1x104	
  HEK293T/17	
   cells	
  were	
   added	
   to	
   each	
  well	
   and	
   the	
   plates	
  were	
  
incubated	
   for	
   48	
   hours	
   at	
   37°C.	
   Luminescence	
   was	
   evaluated	
   by	
   luminometry	
   using	
   the	
  
Bright-­‐Glo	
  assay	
  system	
  (Promega,	
  UK)	
  (Figure	
  2).	
  
Normaliza5on	
  as	
  percentage	
  of	
  inhibi5on	
  of	
  pseudotype	
  virus	
  entry	
  (neutraliza5on),	
  and	
  the	
  
half	
  maximal	
  inhibitory	
  concentra5ons	
  (IC50)	
  were	
  calculated	
  with	
  Prism	
  version	
  6	
  (GraphPad	
  
SoTware)	
  and	
  expressed	
  as	
  reciprocal	
  of	
  the	
  dilu5ons.	
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RESULTS	
  
	
  
For	
  each	
  group	
  2	
  virus	
  the	
  IC50	
  distribu5on	
  of	
  the	
  sera	
  collected	
  before	
  and	
  aTer	
  vaccina5on	
  
were	
  reported	
  on	
  Box-­‐and-­‐Whisker	
  plots	
  (Figure	
  3)	
  for	
  comparison.	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
IC50	
   distribu5ons	
   before	
   and	
   aTer	
   vaccina5on	
   are	
   different	
   in	
   shape	
   and	
   a	
   shiT	
   of	
   IC50	
  
medians	
   and	
   IC50	
   interquar5le	
   range	
   is	
   observed.	
   All	
   before	
   and	
   aTer	
   vaccina5on	
   IC50	
  
distribu5ons	
   (with	
   the	
   excep5on	
   of	
   A/chicken/Germany/N49	
   H10	
   distribu5ons)	
   are	
  
sta5s5cally	
   different	
   (p<0.05)	
   using	
   a	
   non-­‐parametric	
  Wilcoxon	
  matched-­‐pairs	
   signed	
   rank	
  
test.	
  	
  
Figure	
  3.	
  	
  Box-­‐and-­‐Whisker	
  plots	
  showing	
  IC50	
  distribu;ons	
  	
  
Figure	
  1:	
  Phylogene;c	
  rela;onship	
  of	
  
influenza	
  A	
  haemagglu;nin	
  subtypes	
  
Figure	
  2:	
  Pseudotype	
  par;cle	
  neutraliza;on	
  assay	
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Group-1
CONCLUSIONS	
  
	
  
In	
  a	
  this	
  study	
  we	
  have	
  shown	
  that:	
  	
  
v  The	
   pseudotype	
   par5cle	
   neutraliza5on	
   assay	
   has	
   increased	
   sensi5vity	
   for	
   detec5ng	
  
neutralizing	
  an5body	
  response.	
  	
  
v  Performing	
   pseudotype	
   par5cle	
   neutraliza5on	
   assays	
   using	
   a	
   panel	
   of	
   influenza	
   A	
  
pseudotypes	
   permits	
   the	
   detec5on	
   of	
   heterosubtypic	
   an5body	
   responses	
   in	
   pa5ents	
  
before	
  and	
  aTer	
  seasonal	
  influenza	
  vaccina5on.	
  	
  
v  The	
  heterosubtypic	
  an5body	
  response	
  is	
  increased	
  and/or	
  can	
  be	
  elicited	
  aTer	
  seasonal	
  
vaccina5on.	
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